El trabajo de muchos investigadores del CIBER-BBN trata de aportar soluciones innovadoras para el diagnóstico y tratamiento de múltiples enfermedades, entre ellas varios tipos de cáncer. En el Día...
Read moreWorld Cancer Day originated in 2000 at the first World Summit Against Cancer, held in Paris. Its aim is to promote research for curing as well as preventing the disease, upgrading patient services and...
Read moreCancer is the second biggest cause of death throughout the world today. Every year 9.6 million people die from it, 65% of them in low- and medium-income countries. Spain shows a similar trend to other...
Read moreEl trabajo ha sido dirigido por Amancio Carnero, investigador del CSIC en IBiS, cuyo grupo es miembro del CIBER de Cáncer (CIBERONC)
Read moreEl IBB-UAB participa en el proyecto “PhasAGE” sobre investigación y difusión de enfermedades relacionadas con la edad, como el cáncer o los trastornos neurodegenerativos, en el campo emergente ...
Read moreThe liver is an organ that has the ability to regenerate after damage since its cells can proliferate and recover lost or affected tissue. A study from the Bellvitge Biomedical Research Institute (IDI...
Read moreLas ecografías permiten ‘ver’ estructuras internas del cuerpo mediante ultrasonidos y las imágenes gamma proporcionan información metabólica a partir de radiotrazadores inyectados en los pacie...
Read more“Although Gregory received cutting edge immunotherapies and targeted therapies, including CAR-T 19 and an allogeneic CAR-T, the disease was very aggressive, and he succumbed to cancer,” explained ...
Read moreThe objective of RENACER is to carry out basic and clinical studies that help to advance the development of therapies for these metastases With prior consent from the patients, surgeons will collec...
Read moreChildhood cancer is considered a rare disease that accounts for about 1% of all U.S. cancer diagnoses. Although pediatric cancer death rates have declined over the past four decades due to improved tu...
Read moreAptadel Therapeutics is a preclinical company co-founded by IDIBELL focused on developing a new platform for targeted therapy against cancer. This platform consists of nanoparticles loaded with therap...
Read more